Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2023 | What role does germline genetic testing have in diagnosing cancer?

Vivek Subbiah • 17 Apr 2023
AACR 2023
General

Vivek Subbiah, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, highlights the need for universal germline genetic testing. Due to the genetic aberrations that frequently occur in various cancers, genetic testing is necessary to improve outcomes. However, germline testing rates are low due to stringent criteria that need to be met. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Vivek Subbiah

1:19
Phase I/II trial of EP0031, a next generation selective RET inhibitor
Vivek Subbiah • 17 Apr 2023
0:59
What does the future hold for precision medicine in oncology?
Vivek Subbiah • 17 Apr 2023
1:04
Highlights from AACR 2022
Vivek Subbiah • 11 Apr 2022
2:04
AACR GENIE: clinical implications of defining genomic alterations in ultra-rare sarcomas
Vivek Subbiah • 11 Apr 2022

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals